LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 83.72 | 27.76 | 6602 | 7055 | 0.9357 | 0.9834 | MN20160318_Q01 | D12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 85.42 | 27.76 | 5039 | 7025 | 0.7172 | 0.9185 | MN20160318_Q01 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 85.42 | 27.76 | 8310 | 7025 | 1.1828 | 1.0425 | MN20160318_Q01 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 85.42 | 27.76 | 1537 | 7025 | 0.2188 | 0.6533 | MN20160318_Q01 | D12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 85.42 | 27.76 | 6739 | 7025 | 0.9592 | 0.9896 | MN20160318_Q01 | D12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 87.13 | 27.76 | 4760 | 6987 | 0.6812 | 0.9060 | MN20160318_Q01 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 87.13 | 27.76 | 8535 | 6987 | 1.2214 | 1.0508 | MN20160318_Q01 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 87.13 | 27.76 | 1364 | 6987 | 0.1952 | 0.6296 | MN20160318_Q01 | D12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 87.13 | 27.76 | 6877 | 6987 | 0.9841 | 0.9960 | MN20160318_Q01 | D12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 88.84 | 27.76 | 4431 | 6965 | 0.6362 | 0.8897 | MN20160318_Q01 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 88.84 | 27.76 | 8745 | 6965 | 1.2556 | 1.0579 | MN20160318_Q01 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 88.84 | 27.76 | 1184 | 6965 | 0.1700 | 0.6013 | MN20160318_Q01 | D12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 88.84 | 27.76 | 7048 | 6965 | 1.0119 | 1.0030 | MN20160318_Q01 | D12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 90.55 | 27.76 | 4280 | 6928 | 0.6177 | 0.8826 | MN20160318_Q01 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 90.55 | 27.76 | 9000 | 6928 | 1.2989 | 1.0668 | MN20160318_Q01 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 90.55 | 27.76 | 1050 | 6928 | 0.1515 | 0.5781 | MN20160318_Q01 | D12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 90.55 | 27.76 | 7199 | 6928 | 1.0390 | 1.0096 | MN20160318_Q01 | D12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 92.25 | 27.76 | 4107 | 6873 | 0.5975 | 0.8746 | MN20160318_Q01 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 92.25 | 27.76 | 9288 | 6873 | 1.3513 | 1.0772 | MN20160318_Q01 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 92.25 | 27.76 | 896 | 6873 | 0.1304 | 0.5479 | MN20160318_Q01 | D12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 92.25 | 27.76 | 7287 | 6873 | 1.0602 | 1.0148 | MN20160318_Q01 | D12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 93.96 | 27.76 | 4002 | 6849 | 0.5843 | 0.8692 | MN20160318_Q01 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 93.96 | 27.76 | 9546 | 6849 | 1.3938 | 1.0853 | MN20160318_Q01 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 93.96 | 27.76 | 758 | 6849 | 0.1107 | 0.5161 | MN20160318_Q01 | D12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 93.96 | 27.76 | 7428 | 6849 | 1.0845 | 1.0205 | MN20160318_Q01 | D12 |